Cargando…

SAT397 A Low Dose Cyproterone Acetate In Feminizing Hormone Treatment

Disclosure: S. Korpaisarn: None. J. Arunakul: None. K. Chaisuksombat: None. T. Rattananukrom: None. Background: A feminizing hormone therapy (FHT) for transgender women (TW) who have not undergone gonadectomy consists of estrogens and antiandrogens. Cyproterone acetate (CPA) is the most common antia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korpaisarn, Sira, Arunakul, Jiraporn, Chaisuksombat, Kewalin, Rattananukrom, Teerapong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Transgender Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554800/ http://dx.doi.org/10.1210/jendso/bvad114.2068

Ejemplares similares

SAT409 Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study
por: Yaish, Iris, et al.
Publicado: (2023)

Characterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study
por: Rutnin, Suthinee, et al.
Publicado: (2023)

SAT413 Feminising Gender Affirming Hormone Therapy Prolongs QTc Interval
por: Angus, Lachlan, et al.
Publicado: (2023)

SAT406 Evaluation Of The Emotional And Cognitive Effects Of Hormone Therapy In Transgender Men And Women
por: Yaish, Iris, et al.
Publicado: (2023)

SAT412 Effects Of Gender-Affirming Hormone Therapy On The Connectivity Of Intrinsic Brain Networks
por: Pedreira, Clarissa C, et al.
Publicado: (2023)

SAT411 The Influence Of Gender Affirming Hormone Therapy On Markers Of Platelet Activation In Transgender Women
por: van Zijverden, L Mees, et al.
Publicado: (2023)

SAT645 Cardiac Autonomic Modulation In Transgender Men Under Gender-affirming Hormone Therapy
por: Moreira Allgayer, Roberta Martins Costa, et al.
Publicado: (2023)

SAT410 Echocardiogram Analysis Of Transgender Women Amateur Athletes Undergoing Gender-affirming Hormone Therapy
por: Mobilia Alvares, Leonardo Azevedo, et al.
Publicado: (2023)

SAT416 The Incidence Of Autoimmune Disease In Transgender People After Initiation Of Gender-Affirming Hormone Therapy
por: Wiepjes, Chantal, et al.
Publicado: (2023)

SAT405 Bone Analysis Of Transgender Women Amateur Athletes Undergoing Gender-affirming Hormone Therapy
por: dos Santos, Lívia Marcela, et al.
Publicado: (2023)

SAT403 Long-term Metabolic Effects Of Gonadotropin Releasing Hormone Agonist (GnRH) Therapy In Transgender Women Veterans
por: Le, Guillaume, et al.
Publicado: (2023)

SAT647 Quantifying The Effects Of Gender-Affirming Hormone Therapy On Bone Density Of Transgender Patients: Emerging Results Of A Single-center Study
por: Godar, Cassandra M, et al.
Publicado: (2023)

SAT646 Cutaneous Manifestations In Adults With Gender Dysphoria Under Treatment Hormonal In External Consultation Of The Hospital De San José , Bogotá Colombia
por: Cortes, Henry Tovar
Publicado: (2023)

SAT399 Are Gender-affirming Hormone Therapy Duration And Body Mass Index Associated With Bone Mineral Density In Transgender And Gender Diverse Adults?
por: Iwamoto, Sean J, et al.
Publicado: (2023)

SAT420 Bone Health In Transgender People
por: Grande, Giuseppe, et al.
Publicado: (2023)

SAT394 Over-representation Of Adoptees Among Transgender Subjects Seeking Gender-Affirming-Hormonal-Therapy (GAHT) In A Large Tertiary Medical Center
por: Yaish, Iris, et al.
Publicado: (2023)

SAT644 Gender Affirming Hormone Therapy (GHAT) In Adult Male-to-female Mice Increases Cortical And Trabecular Bone, Resulting In An Increase In Bone Strength
por: Zajac, Jeffrey D, et al.
Publicado: (2023)

SAT396 Transgender Care From The VA Perspective
por: Nayak, Pratima R
Publicado: (2023)

SAT408 Assessment Of Family Planning Readiness In Transgender Youth
por: Conard, Ryan Steven, et al.
Publicado: (2023)

SAT407 Hematospermia In Transgender Woman Revealing Occult Endometriosis
por: Coleman-Belin, Janet C, et al.
Publicado: (2023)

SAT395 Gender Dysphoria In A Patient With Ovotesticular Disorder Of Sex Development
por: Moreno, Telma, et al.
Publicado: (2023)

SAT391 Supratherapeutic Estrogen Levels in Transgender Women Likely From Sublingual Estradiol
por: Jalal, Erica, et al.
Publicado: (2023)

SAT400 Evaluation Of Lipid Profile Of Transgender Women On Long-Term Estrogen Therapy
por: Mobilia Alvares, Leonardo Azevedo, et al.
Publicado: (2023)

SAT392 A Case Of Idiopathic Intracranial Hypertension in Gender Dysphoria: Is Testosterone The Culprit?
por: Saad-Omer, Suhail, et al.
Publicado: (2023)

SAT421 Near Term Cardiometabolic Outcomes of Testosterone Therapy In Transgender Boys And Men
por: Dey, Justin, et al.
Publicado: (2023)

SAT402 A Multimodal Curriculum To Improve Medical Student Gender-affirming Communication Skills
por: Jones, Robert Benson, et al.
Publicado: (2023)

SAT417 Comparison Of Mental Health Status In Transgender And Gender Diverse Versus Cisgender People
por: Pedreira, Clarissa C, et al.
Publicado: (2023)

SAT398 Pubertal Status And Trends In Gender Affirming Treatment Of Transgender And Gender Diverse Youth
por: Lin, Cathy, et al.
Publicado: (2023)

SAT414 Gender Identity And Sexual Orientation Among Patients Evaluated By Psychiatric In A Pediatric ED
por: Alejandro, Diaz, et al.
Publicado: (2023)

SAT419 Characteristics Of Trans Male Children And Adolescents Care Followed Up In A Children Hospital
por: Esposito, Mariela, et al.
Publicado: (2023)

SAT418 Nurse-Led Care For Transgender And Gender Diverse Individuals: A Cross-Sectional Study Of International Context And Practice
por: Greenspan, Debra Lynn, et al.
Publicado: (2023)

SAT393 Resilience And Resistance In The Face Of Stigma And Trauma: A Qualitative Study Of Transgender People’s Reactions To Interactions With The Healthcare System
por: Stroumsa, Daphna, et al.
Publicado: (2023)

SAT415 Development Of A Novel, Preclinical Swine Model Of Transgender Men To Assess Testosterone Impact On Insulin Sensitivity And Whole-Body Metabolism
por: Mahabir, Nirvana, et al.
Publicado: (2023)

SAT404 Achieving Both Target Testosterone And Target Estradiol Levels May Not Be Practical In All Trans Feminine Users Of Estradiol - Which To Prioritize?
por: Slack, Daniel, et al.
Publicado: (2023)

SAT401 The Aftermath Of Pueraria mirifica: A Case Of Hypertriglyceridemia And Necrotizing Pancreatitis In A Non-binary Individual With Surreptitious Use Of Oral Estrogenic Compounds
por: Tobolsky, Seth, et al.
Publicado: (2023)

OR31-02 Persistence Of Gender Identity And Hormone Therapy Use In Transgender Adolescents: A Retrospective Cohort Study
por: Gupta, Pranav, et al.
Publicado: (2023)

OR31-03 Testosterone Gender-affirming Hormonal Therapy Is Associated With Decreased Cerebral Blood Flow In Transgender Teens
por: Cote, Samantha, et al.
Publicado: (2023)

OR31-05 Long-Term Effects Of Gender Affirming Hormone Therapy On Insulin Sensitivity, Insulin Secretion, And Glucose Tolerance
por: Pinkson, Sheila, et al.
Publicado: (2023)

OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals
por: van Eeghen, Sarah A, et al.
Publicado: (2023)

OR31-01 The Dose-dependent Effect Of Estrogen On Bone Mineral Density In Trans Girls
por: Boogers, Lidewij S, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iaed5fsgvaouvbu00u1voflrmb